4.00

2.68% -0.11

Journey Medical Corp (DERM)

Overview News Price History Financials Discussions Forecast

Journey Medical Corp stock is traded at $4.00, with a volume of 96,262. It is down -2.68% in the last 24 hours and down -22.48% over the past month. Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Previous Close:

$4.11

Open:

$4.14

24h Volume:

96,262

Relative Volume:

0.89

Market Cap:

$83.56M

Revenue:

$79.89M

Net Income/Loss:

$-12.35M

P/E Ratio:

-4.8193

EPS:

-0.83

Net Cash Flow:

$32.92M

1W Performance:

+0.00%

1M Performance:

-22.48%

6M Performance:

-28.70%

1Y Performance:

-25.51%

1-Day Range:

$3.91

$4.385

1-Week Range:

$3.7801

$4.48

52-Week Range:

$2.85

$6.8899

Journey Medical Corp Stock (DERM) Company Profile

Name

Journey Medical Corp

Sector

Healthcare (1233)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

480-434-6670

Address

9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE

Employee

Twitter

Next Earnings Date

2024-08-12

Latest SEC Filings

DERM's Discussions on Twitter

Compare DERM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DERM Journey Medical Corp	4.00	83.56M	79.89M	-12.35M	32.92M	-0.83
ZTS Zoetis Inc	165.02	74.45B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.49	42.91B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.24	41.98B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	21.49	24.35B	16.77B	-959.00M	1.37B	-0.85
VTRS Viatris Inc	11.96	14.28B	15.05B	-883.30M	1.89B	-0.74

Journey Medical Corp Stock (DERM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-22-24	Initiated	Rodman & Renshaw	Buy
Jun-28-24	Resumed	ROTH MKM	Buy
Dec-07-21	Initiated	B. Riley Securities	Buy

Journey Medical Corp Stock (DERM) Latest News

Jan 09, 2025

DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management - Dermatology Times

Jan 09, 2025

LAVA Therapeutics NV (LVTX)’S -5.56% Retreat Makes It Worth Considering Again - Stocks Register

Jan 09, 2025

Malaysia’s education, business, healthcare AI journey in 2024 - The Malaysian Reserve

Jan 02, 2025

Dec 23, 2024

Bridgebio’s Attruby FDA nod boosts stock; 10 November approvals - BioWorld Online

Dec 23, 2024

Dec 22, 2024

One Man Shares His Journey With ATTR-CM - Health Central

Dec 22, 2024

Dec 18, 2024

Journey Medical Decline Means Insider Profits Down To US$101k - Simply Wall St

Dec 18, 2024

Dec 16, 2024

Journey Medical Co. (NASDAQ:DERM) Sees Large Increase in Short Interest - MarketBeat

Dec 16, 2024

Dec 12, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Position in Service Properties Trust (NASDAQ:SVC) - Defense World

Dec 12, 2024

Walleye Capital LLC Takes $220,000 Position in The Taiwan Fund, Inc. (NYSE:TWN) - Defense World

Dec 12, 2024

Dec 07, 2024

GE HealthCare - linkedin

Dec 07, 2024

Dec 05, 2024

Injection Perfection Medical Spa Unveils Morpheus8 OptimasMax for Comprehensive Aesthetic Treatments. - StreetInsider.com

Dec 05, 2024

How we help consumers eat well and support their health - Danone

Dec 05, 2024

Our mission - Danone

Dec 05, 2024

Dec 04, 2024

Michelle Borland of Vital Strandz: The Journey to Becoming a Trusted Hair Loss Practitioner for Individuals in the USA - Yahoo Finance

Dec 04, 2024

Nov 29, 2024

TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Journe - GuruFocus.com

Nov 29, 2024

Nov 28, 2024

Palmar Hyperhidrosis Pipeline Trends 2024: Clinical Trials, - openPR

Nov 28, 2024

Nahdi Medical Company solidifies its position as the largest primary healthcare provider in the Kingdom - ZAWYA

Nov 28, 2024